Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood

被引：3
|
作者：
Matsumura, T
Kami, M [1 ]
Saito, T
Sakamaki, H
Hirai, H
机构：
[1] Univ Tokyo, Fac Med, Dept Haematol & Oncol, Bunkyo Ku, Tokyo 1138655, Japan
[2] Tokyo Metropolitan Komagome Hosp, Dept Haematol, Tokyo, Japan
来源：
LANCET | 1999年 / 353卷 / 9154期
关键词：
D O I：
10.1016/S0140-6736(05)76119-5
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：752 / 752
页数：1
相关论文
共 50 条
  • [21] Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia
    Coustan-Smith, E
    Behm, FG
    Sanchez, J
    Boyett, JM
    Hancock, ML
    Raimondi, SC
    Rubnitz, JE
    Rivera, GK
    Sandlund, JT
    Pui, CH
    Campana, D
    LANCET, 1998, 351 (9102): : 550 - 554
  • [22] Competitive PCR for quantification of minimal residual disease in acute lymphoblastic leukaemia
    Nyvold, C
    Madsen, HO
    Ryder, LP
    Seyfarth, J
    Engel, CA
    Svejgaard, A
    Wesenberg, F
    Schmiegelow, K
    JOURNAL OF IMMUNOLOGICAL METHODS, 2000, 233 (1-2) : 107 - 118
  • [23] Molecular analysis of minimal residual disease in adult acute lymphoblastic leukaemia
    Foroni, L
    Hoffbrand, AV
    BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY, 2002, 15 (01) : 71 - 90
  • [24] Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia
    C Lutz
    P S Woll
    G Hall
    A Castor
    H Dreau
    G Cazzaniga
    J Zuna
    C Jensen
    S A Clark
    A Biondi
    C Mitchell
    H Ferry
    A Schuh
    V Buckle
    S-E W Jacobsen
    T Enver
    Leukemia, 2013, 27 : 1204 - 1207
  • [25] Quiescent leukaemic cells account for minimal residual disease in childhood lymphoblastic leukaemia
    Lutz, C.
    Woll, P. S.
    Hall, G.
    Castor, A.
    Dreau, H.
    Cazzaniga, G.
    Zuna, J.
    Jensen, C.
    Clark, S. A.
    Biondi, A.
    Mitchell, C.
    Ferry, H.
    Schuh, A.
    Buckle, V.
    Jacobsen, S-E W.
    Enver, T.
    LEUKEMIA, 2013, 27 (05) : 1204 - 1207
  • [26] Minimal residual disease monitoring in childhood acute lymphoblastic leukemia
    Campana, Dario
    CURRENT OPINION IN HEMATOLOGY, 2012, 19 (04) : 313 - 318
  • [27] COMPARISON OF THE PROGNOSTIC SIGNIFICANCE OF MINIMAL RESIDUAL DISEASE AND THE CONVENTIONAL PROGNOSTIC FACTORS IN THE TREATMENT OF ADULT ACUTE LYMPHOBLASTIC LEUKAEMIA PATIENTS
    Lozenov, S.
    Spassov, B.
    Petrov, Y.
    Stoeva, V.
    Yankova, T.
    Ignatova, K.
    Zhechev, Y.
    Staneva, M.
    Mihailova, T.
    Peichev, D.
    Simeonov, S.
    Nihtyanova, D.
    Guenova, M.
    Balatzenko, G.
    Donchev, M.
    Arnaudov, G.
    Mihaylov, G.
    HAEMATOLOGICA, 2016, 101 : 660 - 660
  • [28] MINIMAL RESIDUAL DISEASE IN CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA
    CARR, T
    STEVENS, RF
    LANCET, 1994, 343 (8891): : 190 - 190
  • [29] Clinical value of immunological monitoring of minimal residual disease in acute lymphoblastic leukaemia after allogeneic transplantation
    Sánchez, J
    Serrano, J
    Gómez, P
    Martínez, F
    Martín, C
    Madero, L
    Herrera, C
    García, JM
    Casaño, J
    Torres, A
    BRITISH JOURNAL OF HAEMATOLOGY, 2002, 116 (03) : 686 - 694
  • [30] Prognostic value of minimal residual disease (MRD) in childhood acute lymphoblastic leukemia (ALL) using polymerase chain reaction (PCR)
    Katsibardi, K.
    Palathanasiou, C.
    Moschovi, M.
    Karamolegou, K.
    Lambrou, G. I.
    Tzortzatou-Stathopoulou, F.
    PEDIATRIC BLOOD & CANCER, 2007, 49 (03) : 387 - 387
12345